[Aldose reductase inhibitor--a new way for preventing diabetic lens changes?].
Increased blood sugar levels may influence the refractive power of the lens in juvenile diabetics, and can lead to the rare true diabetic cataract ("snow-storm cataract"). Surplus glucose induces accumulation of the sugar alcohol within the cells, thus generating disturbances of the osmotic balance and finally causing cataract. The enzyme aldose reductase catalyzes the formation of sorbitol. Experiments with animals have shown that aldose reductase inhibitors can prevent the formation of such opacities with streptozotocin-induced diabetes in rats. Numerous aldose reductase inhibitors are now known, but we still have insufficient knowledge to determine whether systemic or local administration is preferable. The mechanisms reported here are not relevant with respect to the frequent occurrence of senile cataract in older diabetics, which has often been described.
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D000818:Animals; D002386:Cataract / Q000517:prevention & control*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications*; D005449:Fluorenes / Q000627:therapeutic use*; D006801:Humans; D006827:Hydantoins / Q000627:therapeutic use*; D051381:Rats; D013401:Sugar Alcohol Dehydrogenases / Q000037:antagonists & inhibitors*
D005449:Fluorenes; D006827:Hydantoins; C045887:alconil; D013401:Sugar Alcohol Dehydrogenases; D000449:Aldehyde Reductase
Aldose Reduktase-Hemmer--ein neuer Weg zur Vermeidung diabetischer Linsenveränderungen?